Breaking James Harden’s Gun Charge Dismissed in Texas After Program Completion Geno Smith Appears in Prime Condition, Says Jets Offensive Coordinator Frank Reich Stefon Diggs Returns to Maryland Roots, Joins Commanders Buffalo Bills Secure O’Cyrus Torrence with Four-Year Contract Extension Moroccan Taxi Drivers Sentenced for Aiding Irregular Migration to Ceuta

Friday August 7, 2026

Reporter

UroGen Pharma Ltd.

3Articles Published

5Communities Covered

Published Articles

Press Release

UroGen Reports $50.4 Million of ZUSDURI Revenue and Provides Second Quarter 2026 Financial Results and Highlights

Aug 6

Press Release

UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103

Jul 15

Press Release

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Jul 8